Probiotics and gastrointestinal conditions: An overview of evidence from the Cochrane Collaboration

Nutrition

Volumn 45, Issue , 2018, Pages 125-134.e11

  Parker, Elizabeth A ^a   Roy, Tina ^b   D'Adamo, Christopher R ^a   Wieland, L Susan ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Geisinger Health Geisinger Commonwealth School of Medicine   (United States)

Author keywords

Diarrhea; Gastrointestinal conditions; Inflammatory bowel disease; Liver disease; Microbiota; Probiotic

Indexed keywords

AMINOSALICYLIC ACID; ANTIBIOTIC AGENT; PLACEBO; PROBIOTIC AGENT;

ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BLOATING; CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; COLONY FORMING UNIT; CROHN DISEASE; DIARRHEA; DIET SUPPLEMENTATION; ESCHERICHIA COLI; FLATULENCE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; LACTOBACILLUS RHAMNOSUS; LENGTH OF STAY; LIVER DISEASE; MORTALITY RATE; NAUSEA; ORAL REHYDRATION THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REMISSION; REVIEW; SACCHAROMYCES BOULARDII; VOMITING; GASTROINTESTINAL TRACT; MICROBIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

GASTROINTESTINAL DISEASES; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85028630123     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2017.06.024     Document Type: Review

References (56)

1. World Health Organization and Food and Agricultural Organization of the United Nations, Probiotics in food: health and nutritional properties and guidelines for evaluation, Volume 85, 2006, World Health Organization and Food and Agricultural Organization of the United Nations, Rome.
2. Clarke, T.C., Black, L.I., Stussman, B.J., Barnes, P.M., Nahin, R.L., Trends in the use of complementary health approaches among adults: United States, 2002–2012. Natl Health Stat Report 79 (2015), 1–16.
3. Bradley, J., Johnson, J., Polito, R., 2015 supplement business report: a tough year for supplements by the numbers. NBJ. 2015 Available at: http://www.newhope.com/managing-your-business/2015-nbj-supplement-business-report-tough-year-supplements-numbers. (Accessed 20 July 2017)
4. Yi, S.H., Jernigan, J.A., McDonald, L.C., Prevalence of probiotic use among inpatients: a descriptive study of 145 U.S. hospitals. Am J Infect Control 44 (2016), 548–553.
5. de Vos, W.M., de Vos, E.A., Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr Rev 70:Suppl 1 (2012), S45–S56.
6. Berggren, A., Lazou Ahren, I., Larsson, N., Onning, G., Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. Eur J Nutr 50 (2011), 203–210.
7. Cao, L., Wang, L., Yang, L., Tao, S., Xia, R., Fan, W., Long-term effect of early-life supplementation with probiotics on preventing atopic dermatitis: a meta-analysis. J Dermatolog Treat 26 (2015), 537–540.
8. Kosiewicz, M.M., Zirnheld, A.L., Alard, P., Gut microbiota, immunity, and disease: a complex relationship. Front Microbiol, 2, 2011, 180.
9. Makino, S., Ikegami, S., Kume, A., Horiuchi, H., Sasaki, H., Orii, N., Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073 R-1. Br J Nutr 104 (2010), 998–1006.
10. Benton, D., Williams, C., Brown, A., Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr 61 (2007), 355–361.
11. Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 105 (2011), 755–764.
12. Kadooka, Y., Sato, M., Imaizumi, K., Ogawa, A., Ikuyama, K., Akai, Y., et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 64 (2010), 636–643.
13. Kadooka, Y., Sato, M., Ogawa, A., Miyoshi, M., Uenishi, H., Ogawa, H., et al. Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. Br J Nutr 110 (2013), 1696–1703.
14. Sanchez, M., Darimont, C., Drapeau, V., Emady-Azar, S., Lepage, M., Rezzonico, E., et al. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. Br J Nutr 111 (2014), 1507–1519.
15. Sullivan, A., Nord, C.E., The place of probiotics in human intestinal infections. Int J Antimicrob Agents 20 (2002), 313–319.
16. Islam, S.U., Clinical uses of probiotics. Medicine, 95, 2016, e2658.
17. Sanders, M.E., Probiotics: definition, sources, selection, and uses. Clin Infect Dis 46:Suppl 2 (2008), S58–S61 discussion S144–S151.
18. Henker, J., Laass, M., Blokhin, B.M., Bolbot, Y.K., Maydannik, V.G., Elze, M., et al. The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. Eur J Pediatr 166 (2007), 311–318.
19. Kruis, W., Schutz, E., Fric, P., Fixa, B., Judmaier, G., Stolte, M., Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 11 (1997), 853–858.
20. Malchow, H.A., Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?. J Clin Gastroenterol 25 (1997), 653–658.
21. Kligler, B., Cohrssen, A., Probiotics. Am Fam Physician 78 (2008), 1073–1078.
22. Cochrane. About Us. vol. 2016. Available at: http://www.cochrane.org/about-us. Accessed May 30, 2017.
23. The Cochrane Collaboration Higgins, J.P.T., Green, S., (eds.) Cochrane handbook for systematic reviews of interventions version 5.1.0, 2011 Available at: http://handbook.cochrane.org. (Accessed 20 July 2017)
24. Jadad, A.R., Cook, D.J., Jones, A., Klassen, T.P., Tugwell, P., Moher, M., et al. Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA 280 (1998), 278–280.
25. Jorgensen, A.W., Hilden, J., Gotzsche, P.C., Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ, 333, 2006, 782.
26. Moseley, A.M., Elkins, M.R., Herbert, R.D., Maher, C.G., Sherrington, C., Cochrane reviews used more rigorous methods than non-Cochrane reviews: survey of systematic reviews in physiotherapy. J Clin Epidemiol 62 (2009), 1021–1030.
27. Tricco, A.C., Tetzlaff, J., Pham, B., Brehaut, J., Moher, D., Non-Cochrane vs. Cochrane reviews were twice as likely to have positive conclusion statements: cross-sectional study. J Clin Epidemiol 62 (2009), 380–386.e381.
28. Useem, J., Brennan, A., LaValley, M., Vickery, M., Ameli, O., Reinen, N., et al. Systematic differences between Cochrane and non-Cochrane meta-analyses on the same topic: a matched pair analysis. PLoS One, 10, 2015, e0144980.
29. Windsor, B., Popovich, I., Jordan, V., Showell, M., Shea, B., Farquhar, C., Methodological quality of systematic reviews in subfertility: a comparison of Cochrane and non-Cochrane systematic reviews in assisted reproductive technologies. Hum Reprod 27 (2012), 3460–3466.
30. Pammi, M., Abrams, S.A., Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev, 2015, CD007137.
31. Saraswati, S., Sitaraman, R., Aging and the human gut microbiota-from correlation to causality. Front Microbiol, 5, 2015, 764.
32. Guyatt, G.H., Oxman, A.D., Vist, G.E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336 (2008), 924–926.
33. Goldenberg, J.Z., Lytvyn, L., Steurich, J., Parkin, P., Mahant, S., Johnston, B.C., Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev, 2015, CD004827.
34. Bernaola Aponte, G., Bada Mancilla, C.A., Carreazo Pariasca, N.Y., Rojas Galarza, R.A., Probiotics for treating persistent diarrhoea in children. Cochrane Database Syst Rev, 2010, CD007401.
35. Allen, S.J., Martinez, E.G., Gregorio, G.V., Dans, L.F., Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev, 2010, CD003048.
36. Goldenberg, J.Z., Ma, S.S., Saxton, J.D., Martzen, M.R., Vandvik, P.O., Thorlund, K., et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev, 2013, CD006095.
37. Pillai, A., Nelson, R., Probiotics for treatment of Clostridium difficile-associated colitis in adults. Cochrane Database Syst Rev, 2008, CD004611.
38. Rolfe, V.E., Fortun, P.J., Hawkey, C.J., Bath-Hextall, F., Probiotics for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev, 2006, CD004826.
39. Butterworth, A.D., Thomas, A.G., Akobeng, A.K., Probiotics for induction of remission in Crohn's disease. Cochrane Database Syst Rev, 2008, CD006634.
40. Doherty, G., Bennett, G., Patil, S., Cheifetz, A., Moss, A.C., Interventions for prevention of post-operative recurrence of Crohn's disease. Cochrane Database Syst Rev, 2009, CD006873.
41. Naidoo, K., Gordon, M., Fagbemi, A.O., Thomas, A.G., Akobeng, A.K., Probiotics for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev, 2011, CD007443.
42. Mallon, P., McKay, D., Kirk, S., Gardiner, K., Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev, 2007, CD005573.
43. Chande, N., McDonald, J.W., Macdonald, J.K., Interventions for treating collagenous colitis. Cochrane Database Syst Rev, 2008, CD003575.
44. Singh, S., Stroud, A.M., Holubar, S.D., Sandborn, W.J., Pardi, D.S., Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev, 2015, CD001176.
45. Lirussi, F., Mastropasqua, E., Orando, S., Orlando, R., Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database Syst Rev, 2007, CD005165.
46. McGee, R.G., Bakens, A., Wiley, K., Riordan, S.M., Webster, A.C., Probiotics for patients with hepatic encephalopathy. Cochrane Database Syst Rev, 2011, CD008716.
47. Yaffe, J., Montgomery, P., Hopewell, S., Shepard, L.D., Empty reviews: a description and consideration of Cochrane systematic reviews with no included studies. PLoS One, 7, 2012, e36626.
48. Cheifetz, A.S., Gianotti, R., Luber, R., Gibson, P.R., Complementary and alternative medicines used by patients with inflammatory bowel diseases. Gastroenterology 152 (2017), 415–429.
49. Elzouki, A.N., Probiotics and liver disease: where are we now and where are we going?. J Clin Gastroenterol 50:Suppl 2 (2016), S188–S190.
50. Senok, A.C., Ismaeel, A.Y., Botta, G.A., Probiotics: facts and myths. Clin Microbiol Infect 11 (2005), 958–966.
51. Brahe, L.K., Astrup, A., Larsen, L.H., Can We prevent obesity-related metabolic diseases by dietary modulation of the gut microbiota?. Adv Nutr 7 (2016), 90–101.
52. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (2010), 59–65.
53. Riviere, A., Selak, M., Lantin, D., Leroy, F., De Vuyst, L., Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol, 7, 2016, 979.
54. Gomez-Gallego, C., Pohl, S., Salminen, S., De Vos, W.M., Kneifel, W., Akkermansia muciniphila: a novel functional microbe with probiotic properties. Benef Microbes 7 (2016), 571–584.
55. Williamson, P., Clarke, M., The COMET (Core Outcome Measures in Effectiveness Trials) initiative: its role in improving Cochrane Reviews. Cochrane Database Syst Rev, 2012, ED000041.
56. Ryan R, Cochrane Consumers and Communication Review Group. ‘Cochrane Consumers and Communication Group: meta-analysis. Available at: http://cccrg.cochrane.org. Accessed August 7, 2017.